info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
us US: +1-315-636-4233    uk UK: +44-162-237-0614     in IN: +91-826-083-6500
smrlogonew
  • Home
  • About
    • Why SMR
    • Research Methodology
    • Media Coverage
    • Join Our Team
  • Reports
    • Aerospace and Defense
    • Agriculture
    • Automotive
    • Chemicals and Materials
    • Consumer Goods
    • Energy and Power
    • Equipment and Machinery
    • Food and Beverages
    • Healthcare
    • Information and Communication Technology
    • Semiconductor and Electronics
    • Manufacturing and Construction
  • Our Practices
    • Syndicated Research
    • Consulting Services
    • Custom Research
    • Full-time Engagement Model
  • Insights
    • Press Release
    • Blog
  • Contact
 
Home » Healthcare » Angioplasty Balloons Market - Trend Analysis & Forecast

Angioplasty Balloons Market By Product Type (Normal Balloons, Scoring Balloons, Drug-eluting balloons, Cutting balloon), By Application (Coronary, Peripheral), By End-user (Ambulatory Surgery Centres (ASCs), Hospitals, Catheterization Laboratories), By Geography, Size, Trends, Industry Growth Report, Forecast, 2021-2030

Published On: May-2022   |   Base Year: 2021   |   No Of Pages: 135   |   Historical Data: 2017 - 2020   |   Formats: PDF   |   Report ID: 40189351

Industry Report and Statistics (Facts & Figures) - Sales Volume, Procedure Conducted & ASP by Product, Application & End-User

The global angioplasty balloons market will witness a robust CAGR of 4.10%, valued at $2.60 billion in 2021, expected to appreciate and reach $3.73 billion by 2030, confirms Strategic Market Research. North America significantly held the maximum share of the market in 2020, and it is expected to continue its sheer dominance throughout the forecasted period. Angioplasty, also termed balloon angioplasty & percutaneous transluminal angioplasty, is considered a MI (minimally invasive) endovascular procedure. It is used to widen narrowed or obstructed arteries or veins to treat arterial atherosclerosis. A balloon-tipped catheter is implemented in angioplasty to clear a blocked blood vessel and improve blood flow throughout the human body. The angioplasty technique is primarily performed in a cardiac attack. The Global Health and Wellness Report of 2018 confirmed that approximately 40% of the adult population in the United States had been diagnosed with cardiovascular disease. Also, according to the Foundation de France, one out of every three adults in France is at risk of developing cardiovascular disease. In France, around 130,000 heart attacks and 120,000 strokes occur each year, which in turn is increasing the demand for Angioplasty balloons globally, thereby driving its industry growth.

Angioplasty Balloons Market Infographics

Market Drivers - An Increasing Number of Cardiovascular Diseases, the Impact of Covid 19, Rising Geriatric Population

  • According to the World Health Organization (WHO), the United States has roughly 8 million people with peripheral artery disease. Coronary heart disease is the major cause of mortality in the country, accounting for over half of fatalities. Over the predicted period, the prevalence of these disorders is expected to rise. Furthermore, a rising elderly population with heart disease and diabetes is predicted to drive up the demand for angioplasty balloon catheters throughout the forecasted period. Also, as per a survey performed by the Health Protection Agency, around 610,000 individuals die in the U.S. every year due to cardiac abnormalities, with the number continuing to rise in due course of time. 

 

  • According to the World Aging Population Report, the worldwide population of netizens aged 65 or more was estimated to be about 702.9 million in 2019, which is projected to rise up to 1548.9 million by 2050. As the senior population grows, chronic illnesses are predicted to rise, leading to more hospitalizations and surgeries.

 

  • Furthermore, the increasing cases of Atherosclerosis and Carotid artery injury are increasing the demand for Percutaneous Transluminal Coronary Angioplasty, Coronary artery stents, Brachytherapy, Carotid artery angioplasty, Cerebral angioplasty, heart balloon angioplasty, and Cardiac Catheterization, hence driving the overall angioplasty balloons market growth.

global angioplasty balloons market by share 2020-2030

Restraints - Low Awareness in Underdeveloped Countries

  • In developing nations, a lack of knowledge will hinder market expansion. In addition, the industry will likely face challenges due to the scarcity of experienced medical personnel, high surgical procedure costs, and a lack of favorable reimbursement policies in emerging and undeveloped nations. 

 

  • Furthermore, increased product recalls and clinical risks or consequences of surgical procedures may stifle the industry's growth.

 

Opportunities - Increasing Prevalence of Target Illnesses

  • One of the major reasons driving the market expansion is an increase in the prevalence of target diseases. According to the WHO (World Health Organization), cardiovascular diseases impact 485.6 million people worldwide, with 17.9 million deaths. This figure represents 35% of all fatalities worldwide. Furthermore, heart attacks account for 85 percent of all fatalities associated with cardiovascular disease. Also, increasing awareness of the minimally invasive surgical procedures, Balloon angioplasty success rate, the launch of innovative products, and the rising prevalence of coronary and peripheral artery diseases in developing countries are expected to cater to ample opportunities for industry growth in the future.

 

  • Furthermore, the rise in usage of drug-eluting stents and the untapped potential of emerging markets contribute to lucrative market growth opportunities.

angioplasty balloons market by application 2020-2030

Market Analysis Of Different Segments Covered in the Report

Based on the Product Type

  • Normal Balloons

  • Scoring Balloons

  • Drug-eluting balloons

  • Cutting balloon

 

Based on Application

  • Coronary 

  • Peripheral 

 

Based on End-user

  • Ambulatory Surgery Centres (ASCs)

  • Hospitals

  • Catheterization Laboratories 

 

Regional Coverage Analysis

North America

  • The U.S.

  • Canada

  • Mexico

  • Rest of North America

 

Europe

  • France

  • Germany

  • U.K

  • Spain

  • Italy

  • Rest of Europe

 

Asia Pacific

  • China

  • India

  • Japan

  • Australia

  • Rest of APAC

 

LAMEA

  • Brazil

  • Saudi Arabia

  • South Africa

  • Rest of LAMEA

angioplasty balloons market by end user 2020-2030

Product Type Analysis & Insights

The Normal Balloons segment held the largest industry share in 2020 due to the lower cost of these devices, supportive government laws and approval processes, and attractive reimbursement policies. However, the fastest-growing segment is expected to be the Drug-Eluting Balloons (DEBs). Favorable reimbursement procedures resulted in an increase in DEB sales, which is expected to continue in the foreseeable years. The launch of new devices, the benefits of DEBs over ordinary balloons, and the cheaper cost of DEBs compared to stents contribute to the increasing growth of this segment.

 

Application Analysis & Insights

Based on the Application, the Coronary segment held the largest angioplasty balloons market share in 2020 because of the high prevalence of coronary artery disease, one of the prominent types of heart disease. According to the CDC, these diseases cause approximately 370,000 deaths per year globally. Also, the World Health Organization asserted that Heart disease had remained the leading cause of death worldwide for the last 20 years. The number of fatalities from heart diseases increased from 2 Mn in 2000 to approximately 9 million in 2019. On the other hand, because of the increasing number of approvals for innovative drugs and devices, Peripheral artery diseases are expected to be the fastest-growing segment in the upcoming years. Furthermore, increased awareness of disorders affecting the peripheral arteries and the availability of improved products are predicted to propel the market forward. The CDC has announced that approximately 6.5 million people aged 40 years or older in the United States suffer from PAD. 

 

End-User Analysis & Insights

Based on the End-user, the Hospital segment is expected to have the largest industry share in 2020. Advanced healthcare infrastructure, rising availability of skilled healthcare professionals, and affordability drive this segment's supremacy. According to a report published by the Advanced Medical Technology Association (AdvaMed), India's move to cap the maximum prices of various cardiovascular surgical instruments has reduced angioplasty procedure costs in tier 1 by up to 18 percent.

 

Region Analysis & Insights

North America held the maximum share. The region's major drivers include the prevalence of significant players, a shift in FDA policy in the United States, and an increase in the frequency of percutaneous coronary procedures. The American College of Cardiology confirmed that around 1.2 million angioplasties are done yearly in the United States. Due to the rising healthcare spending and excellent government support, the Asia Pacific is likely to be the most attractive and fastest-growing geographical market throughout the estimated period.

 

Angioplasty Balloons Market Report Coverage

Report Attribute

Details

Forecast Period

2021 - 2030

The market size value in 2021

USD 2.60 billion

The revenue forecast in 2030

USD 3.73 billion

Growth rate

CAGR of approximately 4.10%

The base year for estimation

2021

Unit

USD Billion, CAGR (2021 - 2030)

Segmentation

By Product, By Application, By End-user, By Region

By Product

Normal Balloons, Scoring Balloons, Drug-eluting balloons, Cutting balloon

By Application

Coronary, Peripheral 

By End-user

Ambulatory Surgery Centres (ASCs), Hospitals, Catheterization Laboratories

By Region

Asia Pacific, North America, Europe, LAMEA

Country Scope

U.S., Canada, France, Germany, U.K., China, Japan, India, South Korea, Mexico, Brazil, U.A.E. etc.

Company Usability Profiles

Spectranetics Corp., Becton, Medtronic PLC, Boston Scientific Corporation; Cook Medical, Inc., Dickinson and Company (C. R. Bard, Inc.), Cardinal Health (Cordis), ENDOCOR GmbH, Johnson & Johnson, Abbott Laboratories, etc.

 

Angioplasty Balloons Market Competitive Landscape Analysis

The competitive landscape analysis provides information about the crucial competitors prevailing in the global environment. The comparison is performed based on overall revenue generation, market initiatives, company overview, investment in R&D, company financials, company strengths and weaknesses, global presence, production capacity, production sites and facilities, market potential, etc.

 

  • Boston Scientific Corporation

  • Medtronic PLC

  • Spectranetics Corp.

  • Becton, Dickinson and Company 

  • Abbott Laboratories

  • Cook Medical, Inc.

  • Cardinal Health 

  • ENDOCOR GmbH

  • Johnson & Johnson

  • SINOMED

  • Biotronik

angioplasty balloons market by region 2020-2030

 

Recent Developments

  • In August 2021, by collaborating with the National University of Ireland Galway (NUI Galway), SINOMED, a prominent global medical device company, announced the first commercial implantation of the HT Supreme Drug-Eluting Stent (DES) at University Hospital Galway, thereby promoting and advancing the European launch.

 

  • In January 2021, The JADE 0.014", 0.018", and 0.035" OTW non-compliant peripheral balloon dilatation catheter series from OrbusNeich Medical Co. Ltd received authorization from the US Food and Drug Administration (FDA). The JADE OTW Balloon Dilatation Catheter for Percutaneous Transluminal Angioplasty (PTA) is an over-the-wire balloon catheter for percutaneous transluminal angioplasty of obstructed native arteries and synthetic arteriovenous dialysis fistulae.

 

  • In November 2020, InfinityAngioplasty Balloon Co. announced the completion of a First-in-Human clinical study for their novel angioplasty balloon platform, the Infinity Angioplasty Balloon Catheter. 

 

  • In June 2020, the FDA approved the device for PTA treatment of peripheral artery diseases in peripheral vessels such as the iliac, femoral, popliteal, and infra-popliteal arteries and the treatment of A.V. dialysis fistulae.

 

Frequently Asked Question About This Report

The global angioplasty balloons market is expected to grow at a compound annual growth rate (CAGR) of 4.10% from 2021 to 2030 to reach USD 3.73 billion by 2030.

Balloon angioplasty is a procedure used to unblock blocked or constricted arteries. It entails placing a catheter with a balloon attached to an artery. The balloon is inflated where plaque deposits have blocked or restricted blood flow.

In Gruentzigs time, the first angioplasty balloons were manufactured of flexible PVC (polyvinyl chloride). Cross-linked polyethylene was employed in the next generation of balloon technology. Polyethene terephthalate (PET) or nylon are the most common materials used in the twenty-first century.

Balloon angioplasty surgery is a procedure in which interventional cardiologists open constricted arteries. They employ a catheter, which is a long, thin tube with a tiny balloon at the tip. They inflate the balloon (using an angioplasty balloon inflation device), flattening or compressing the plaque against the arterial wall at the obstruction site.

The key segments inculcated in the angioplasty balloons market are Product Type, Application, End-users, and Region.

The global angioplasty balloons market share was around USD 2.60 Billion 2021, and it is forecasted to grow at a CAGR of 4.10% from 2021 to 2030. As a result, the global angioplasty balloons market Forecast suggests reaching around USD 3.73 Billion by 2030.

The global angioplasty balloons market size was around $2.60 Billion in 2021 and is predicted to reach $3.73 Billion in 2030.


Sources

https://www.ahajournals.org/doi/10.1161/CIR.0000000000000558

https://www.fondationdefrance.org/en/cardiovascular-disease

https://www.cdc.gov/heartdisease/facts.htm

https://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2019-Highlights.pdf

 

 

1.   Introduction

       1.1. Study Objective

       1.2. Market Definition        

       1.3. Study Scope

              1.3.1. Markets Covered

              1.3.2. Geographic Scope

              1.3.3. Years Considered

              1.3.4. Stakeholders

2.   Research Methodology

       2.1. Data Procurement

       2.2. Paid Database

              2.2.1. Secondary Data

                     2.2.1.1. Key Secondary sources

              2.2.2. Primary Data

                     2.2.2.1 Primary sources

                     2.2.2.2. Key industry insights

                     2.2.2.3. Primary interviews with experts

                     2.2.2.4. Key primary respondent list

       2.3. Market Size Estimation

       2.4. Bottom-Up and Top-Down Approaches

              2.4.1.     Bottom-Up Approach

                     2.4.1.1.         Approach for arriving at market size by bottom-up analysis

              2.4.2.     Top-Down Approach

                     2.4.2.1.         Approach for Capturing Market Size by Top-Down Analysis

       2.5. Market Breakdown and Data Triangulation

       2.6. Research Methodology

       2.7. Risk Assessment

3.  Executive Summary

       3.1  Angioplasty Balloons Market: Post-Covid-19

              3.1.1      Actual Scenario

              3.1.2      Pessimistic Scenario

              3.1.3      Optimistic Scenario

              3.1.4      Market Summary

4. Industry Outlook

       4.1  Market Snapshot

       4.2  Regional  Analysis

              4.2.1      market, by region, 2021-2030 (USD Million)

       4.3  By Product  Analysis

              4.3.1      market, By Product, 2021-2030 (USD Million)

       4.4  By End-user  Analysis

              4.4.1      market, By End-user, 2021-2030 (USD Million)

       4.5  Application  Analysis

              4.5.1      market, By Application, 2021-2030 (USD Million)

       4.6  Value Chain Analysis

       4.7  Market Variable Analysis

              4.7.1      Market Drivers Analysis

              4.7.2      Market Restraints Analysis

       4.8  Environment Analysis Tool

              4.8.1      PEST analysis

              4.8.2      Porter’s analysis

       4.9 Penetration & Growth Prospect Mapping

5. Market Dynamics

       5.1. Introduction

       5.2. Market Dynamics

              5.2.1.     Drivers

              5.2.2.     Restraints

              5.2.3.     Opportunities

              5.2.4.     Challenges

       5.3. Impact of Covid-19 On Market

       5.4. Value Chain Analysis

       5.5. Ecosystem

       5.6. Patent Analysis

       5.7. Trade Analysis

       5.8. Tariff Analysis

       5.9. Case Study Analysis

5.10.      Porter’s Five Forces Analysis

              5.10.1    Threat of New Entrants

              5.10.2    Threat of Substitutes

              5.10.3    Bargaining Power of Buyers

              5.10.4    Bargaining Power of Suppliers

              5.10.5    Degree of Competition

       5.11.              Application Analysis

              5.11.1.   Trends in Application (2014-2020)

              5.11.2.   Trends in Application (2021-2028)

       5.12.              Pricing Analysis

              5.12.1.   Average Price Trend Analysis (By Region, By Country)

6. Competitive & Vendor Landscape

       6.1. Company Market Share Analysis

       6.2. Manufacturing Sites, Area Served, Product Product

       6.3. Market Competitive Situation and Trends

       6.4. Manufacturers Mergers & Acquisitions, Expansion Plans

7. Global Market: By Product Segment Analysis

       7.1. Introduction

       7.2. Sales Volume & Revenue Analysis (2021-2030)

       7.3. Normal Balloons

              7.3.1. Normal Balloons market, 2021-2030 (USD Million)

       7.4. Scoring Balloons

              7.4.1. Scoring Balloons market, 2021-2030 (USD Million)

       7.5. Drug-eluting balloons

              7.5.1. Drug-eluting balloons market, 2021-2030 (USD Million)

       7.6. Cutting balloon

              7.6.1. Cutting balloon market, 2021-2030 (USD Million)

8. Global Market: By Application Segment Analysis

       8.1. Introduction

       8.2. Sales Volume & Revenue Analysis (2021-2030)

       8.3. Coronary

              8.3.1.     Coronary market, 2021-2030 (USD Million)

       8.4. Peripheral

              8.4.1.     Peripheral market, 2021-2030 (USD Million)

9. Global Market: By End-User Segment Analysis

       9.1. Introduction

       9.2. Sales Volume & Revenue Analysis (2021-2030)

       9.3. Ambulatory Surgery Centres (ASCs)

              9.3.1.     Ambulatory Surgery Centres (ASCs) market, 2021-2030 (USD Million)

       9.4. Hospitals

              9.4.1.     Hospitals market, 2021-2030 (USD Million)

       9.5. Catheterization Laboratories

              9.5.1.     Catheterization Laboratories market, 2021-2030 (USD Million)

10. Global Market: Regional Outlook

       10.1 North America

              10.1.1.   North America  market, by By Product, 2021-2030 (USD Million)

              10.1.2.   North America  market, by By End-user, 2021-2030 (USD Million)

              10.1.3.   North America  market, by Application, 2021-2030 (USD Million)

              10.1.4.   North America  market, by Country, 2021-2030 (USD Million)

       10.1.4.1. U.S.

                     10.1.4.1.1.   U.S. market, by By Product, 2021-2030 (USD Million)

                     10.1.4.1.2.   U.S. market, by By End-user, 2021-2030 (USD Million)

                     10.1.4.1.3.   U.S. market, by Application, 2021-2030 (USD Million)

     10.1.4.2.  Canada

                     10.1.4.2.1.   Canada market, by By Product, 2021-2030 (USD Million)

                     10.1.4.2.2.   Canada market, by By End-user, 2021-2030 (USD Million)

                     10.1.4.2.3.   Canada market, by Application, 2021-2030 (USD Million)

10.2. Europe

              10.2.1.   Europe market, by By Product, 2021-2030 (USD Million)

              10.2.2.   Europe market, by By End-user, 2021-2030 (USD Million)

              10.2.3.   Europe market, by Application, 2021-2030 (USD Million)

              10.2.4.   Europe market, by country, 2021-2030 (USD Million)

    10.2.4.1    U.K.

                     10.2.4.1.1.   U.K. market, by By Product, 2021-2030 (USD Million)

                     10.2.4.1.2.   U.K. market, by By End-user, 2021-2030 (USD Million)

                     10.2.4.1.3.   U.K. market, by Application, 2021-2030 (USD Million)

   10.2.4.2.           Germany

                     10.2.4.2.1.   Germany market, by By Product, 2021-2030 (USD Million)

                     10.2.4.2.2.   Germany market, by By End-user, 2021-2030 (USD Million)

                     10.2.4.2.3.   Germany market, by Application, 2021-2030 (USD Million)

   10.2.4.3.           France

                     10.2.4.3.1.   France market, by By Product, 2021-2030 (USD Million)

                     10.2.4.3.2.   France market, by By End-user, 2021-2030 (USD Million)

                     10.2.4.3.3.   France market, by Application, 2021-2030 (USD Million)

    10.2.4.4.          Rest of Europe

                     10.2.4.4.1.   Rest of Europe market, by By Product, 2021-2030 (USD Million)

                     10.2.4.4.2.   Rest of Europe market, by By End-user, 2021-2030 (USD Million)

                     10.2.4.4.3.   Rest of Europe market, by Application, 2021-2030 (USD Million)

       10.3.              Asia Pacific

              10.3.1.   Asia Pacific market, by By Product, 2021-2030 (USD Million)

              10.3.2.   Asia Pacific market, by By End-user, 2021-2030 (USD Million)

              10.3.3.   Asia Pacific market, by Application, 2021-2030 (USD Million)

              10.3.4.   Asia Pacific market, by country, 2021-2030 (USD Million)

   10.3.4.1.           China

                     10.3.4.1.1.   China market, by By Product, 2021-2030 (USD Million)

                     10.3.4.1.2.   China market, by By End-user, 2021-2030 (USD Million)

                     10.3.4.1.3.   China market, by Application, 2021-2030 (USD Million)

   10.3.4.2.           India

                     10.3.4.2.1.   India market, by By Product, 2021-2030 (USD Million)

                     10.3.4.2.2.   India market, by By End-user, 2021-2030 (USD Million)

                     10.3.4.2.3.   India market, by Application, 2021-2030 (USD Million)

   10.3.4.3.           Japan

                     10.3.4.3.1.   Japan market, by By Product, 2021-2030 (USD Million)

                     10.3.4.3.2.   Japan market, by By End-user, 2021-2030 (USD Million)

                     10.3.4.3.3.   Japan market, by Application, 2021-2030 (USD Million)

   10.3.4.4.           South Korea

                     10.3.4.4.1.   South Korea market, by By Product, 2021-2030 (USD Million)

                     10.3.4.4.2.   South Korea market, by By End-user, 2021-2030 (USD Million)

                     10.3.4.4.3.   South Korea market, by Application, 2021-2030 (USD Million)

10.3.4.5.              Rest of ASIA PACIFIC

                     10.3.4.5.1.   Rest of ASIA PACIFIC market, by By Product, 2021-2030 (USD Million)

                     10.3.4.5.2.   Rest of ASIA PACIFIC market, by By End-user, 2021-2030 (USD Million)

                     10.3.4.5.3.   Rest of ASIA PACIFIC market, by Application, 2021-2030 (USD Million)

       10.4.              Latin America

              10.4.1.   Latin America market, by By Product, 2021-2030 (USD Million)

              10.4.2.   Latin America market, by By End-user, 2021-2030 (USD Million)

              10.4.3.   Latin America market, by Application, 2021-2030 (USD Million)

              10.4.4.   Latin America market, by country, 2021-2030 (USD Million)

10.4.4.1.              Brazil

                     10.4.4.1.1.   Brazil market, by By Product, 2021-2030 (USD Million)

                     10.4.4.1.2.   Brazil market, by By End-user, 2021-2030 (USD Million)

                     10.4.4.1.3.   Brazil market, by Application, 2021-2030 (USD Million)

10.4.4.2.              Mexico

                     10.4.4.2.1.   Mexico market, by By Product, 2021-2030 (USD Million)

                     10.4.4.2.2.   Mexico market, by By End-user, 2021-2030 (USD Million)

                     10.4.4.2.3.   Mexico market, by Application, 2021-2030 (USD Million)

                     10.4.4.3.       Rest of the Latin America

                     10.4.4.3.1.   Rest of the Latin America market, by By Product, 2021-2030 (USD Million)

                     10.4.4.3.2.   Rest of the Latin America market, by By End-user, 2021-2030 (USD Million)

                     10.4.4.3.3.   Rest of the Latin America market, by Application, 2021-2030 (USD Million)

       10.5.              MEA

              10.5.1.   MEA market, by By Product, 2021-2030 (USD Million)

              10.5.2.   MEA market, by By End-user, 2021-2030 (USD Million)

              10.5.3.   MEA market, by Application, 2021-2030 (USD Million)

              10.5.4.   MEA market, by Region, 2021-2030 (USD Million)

 

11. Competitive Landscape

       11.1 Boston Scientific Corporation

              11.1.1.   Company overview

              11.1.2.   Financial performance

              11.1.3.   Product Portfolio Analysis

              11.1.4.   Strategy & Recent Development

       11.2. Medtronic PLC

              11.2.1.   Company overview

              11.2.2.   Financial performance

              11.2.3.   Product Portfolio Analysis

              11.2.4.   Strategy & Recent Development

       11.3. Spectranetics Corp

              11.3.1.   Company overview

              11.3.2.   Financial performance

              11.3.3.   Product Portfolio Analysis

              11.3.4.   Strategy & Recent Development

       11.4. Becton, Dickinson and Company

              11.4.1.   Company overview

              11.4.2.   Financial performance

              11.4.3.   Product Portfolio Analysis

              11.4.4.   Strategy & Recent Development

       11.5. Abbott Laboratories

              11.5.1.   Company overview

              11.5.2.   Financial performance

              11.5.3.   Product Portfolio Analysis

              11.5.4.   Strategy & Recent Development

       11.6. Cook Medical, Inc

              11.6.1.   Company overview

              11.6.2.   Financial performance

              11.6.3.   Product Portfolio Analysis

              11.6.4.   Strategy & Recent Development

       11.7. Cardinal Health

              11.7.1.   Company overview

              11.7.2.   Financial performance

              11.7.3.   Product Portfolio Analysis

              11.7.4.   Strategy & Recent Development

       11.8. ENDOCOR GmbH

              11.8.1.   Company overview

              11.8.2.   Financial performance

              11.8.3.   Product Portfolio Analysis

              11.8.4.   Strategy & Recent Development

       11.9. Johnson & Johnson

              11.9.1.   Company overview

              11.9.2.   Financial performance

              11.9.3.   Product Portfolio Analysis

              11.9.4.   Strategy & Recent Development

       11.10. SINOMED

              11.10.1. Company overview

              11.10.2. Financial performance

              11.10.3. Product Portfolio Analysis

              11.10.4. Strategy & Recent Development

       11.11. Biotronik

              11.11.1. Company overview

              11.11.2. Financial performance

              11.11.3. Product Portfolio Analysis

              11.11.4. Strategy & Recent Development

 

 

List of Tables (51 Tables)

TABLE 1.  MARKET, By Product, 2021-2030 (USD Million)

TABLE 2.  MARKET FOR Normal Balloons, BY REGION, 2021-2030 (USD Million)

TABLE 3.  MARKET FOR Scoring Balloons, BY REGION, 2021-2030 (USD Million)

TABLE 4.  MARKET FOR Drug-eluting balloons, BY REGION, 2021-2030 (USD Million)

TABLE 5.  MARKET FOR Cutting balloon, BY REGION, 2021-2030 (USD Million)

TABLE 6. MARKET, By End-user, 2021-2030 (USD Million)

TABLE 7. MARKET FOR Ambulatory Surgery Centres (ASCs), BY REGION, 2021-2030 (USD Million)

TABLE 8. MARKET FOR Hospitals, BY REGION, 2021-2030 (USD Million)

TABLE 9. MARKET FOR Catheterization Laboratories, BY REGION, 2021-2030 (USD Million)

TABLE 10. MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 11. MARKET FOR Coronary, BY REGION, 2021-2030 (USD Million)

TABLE 12. MARKET FOR Peripheral, BY REGION, 2021-2030 (USD Million)

TABLE 13. MARKET, BY REGION, 2021-2030 (USD Million)

TABLE 14. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 15. NORTH AMERICA MARKET, By Product, 2021-2030 (USD Million)

TABLE 16. NORTH AMERICA MARKET, By End-user, 2021-2030 (USD Million)

TABLE 17. NORTH AMERICA MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 18. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 19. EUROPE MARKET, By Product, 2021-2030 (USD Million)

TABLE 20. EUROPE MARKET, By End-user, 2021-2030 (USD Million)

TABLE 21. EUROPE MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 22. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 23. ASIA-PACIFIC MARKET, By Product, 2021-2030 (USD Million)

TABLE 24. ASIA-PACIFIC MARKET, By End-user, 2021-2030 (USD Million)

TABLE 25. ASIA-PACIFIC MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 26. LAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 27. LAMEA MARKET, By Product, 2021-2030 (USD Million)

TABLE 28. LAMEA MARKET, By End-user, 2021-2030 (USD Million)

TABLE 29. LAMEA MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 30. Boston Scientific Corporation: COMPANY SNAPSHOT

TABLE 31. Boston Scientific Corporation: OPERATING SEGMENTS

TABLE 32. Medtronic PLC: COMPANY SNAPSHOT

TABLE 33. Medtronic PLC: OPERATING SEGMENTS

TABLE 34. Spectranetics Corp: COMPANY SNAPSHOT

TABLE 35. Spectranetics Corp: OPERATING SEGMENTS

TABLE 36. Becton, Dickinson and Company : COMPANY SNAPSHOT

TABLE 37. Becton, Dickinson and Company: OPERATING SEGMENTS

TABLE 38. Abbott Laboratories: COMPANY SNAPSHOT

TABLE 39. Abbott Laboratories: OPERATING SEGMENTS

TABLE 40. Cook Medical, Inc: COMPANY SNAPSHOT

TABLE 41. Cook Medical, Inc: OPERATING SEGMENTS

TABLE 42. Cardinal Health: COMPANY SNAPSHOT

TABLE 43. Cardinal Health: OPERATING SEGMENTS

TABLE 44. ENDOCOR GmbH: COMPANY SNAPSHOT

TABLE 45. ENDOCOR GmbH: OPERATING SEGMENTS

TABLE 46. Johnson & Johnson: COMPANY SNAPSHOT

TABLE 47. Johnson & Johnson: OPERATING SEGMENTS

TABLE 48. SINOMED: COMPANY SNAPSHOT

TABLE 49. SINOMED: OPERATING SEGMENTS

TABLE 50. Biotronik: COMPANY SNAPSHOT

TABLE 51. Biotronik: OPERATING SEGMENTS

 

 

List of Figures (22 Figures)

Figure 1 Research Methodology Steps

Figure 2 Research Design

Figure 3 Breakdown of Primaries

Figure 4 Research Methodology: Hypothesis Building

Figure 5 Product-Based Estimation

Figure 6 Top 11 Companies with Highest No. Of Patent in Last 9 Years

Figure 7 No. Of Patents Granted Per Year, 2019–2020

Figure 8 Import Data for Angioplasty Balloons, By Country, 2016–2020 (USD Thousand)

Figure 9 Export Data for Angioplasty Balloons, By Country, 2016–2020 (USD Thousand)

Figure 10 Data Triangulation Methodology

Figure 11 Market, By End-user, 2019 vs. 2025 (USD Million)

Figure 12 Market Share, By Application, 2019 vs. 2025 (USD Million)

Figure 13 Market Share, By Product, 2019 vs. 2025 (USD Million)

Figure 14 Geographical Snapshot of the Market

Figure 15 Drug-eluting balloons to Witness Higher CAGR in Market for Product Segment during Forecast Period.

Figure 16 Peripheral to Witness Higher CAGR in Market for Application Segment during Forecast Period.

Figure 17 Hospitals to Witness Higher CAGR in Market for End-user Segment during Forecast Period.

Figure 18 Asia Pacific region Accounted for the Largest Share of the Market, By Regional Basis, in 2019

Figure 19 Drivers, Restraints, Opportunities, and Challenges

Figure 20 North America: Market Snapshot

Figure 21 Asia Pacific: Market Snapshot

Figure 22 Vendor Dive: Evaluation Overview

Choose License Type


$4485
$6449
$8339
Buy Now
"Click to avail the latest sample copy of the report"
Request Sample
"Probe before placing the order"
Pre-Order Enquiry
"Let's optimize your ROI by furnishing the best price"
Request Discount
"Want to curate the report according to your business needs:"
Ask for Customization
Related Reports
Buy Now
Request Sample

Trust Online

  • paypal.png
  • wiretransfers

Follow Us

  • facebook
  • twitter
  • instagram
  • linkedin

Contact Us

  • US: +1-315-636-4233
  • UK: +44-162-237-0614
  • IN: +91-826-083-6500
  • info@strategicmarketresearch.com
  • Strategic Market Research
    26, Broadway Suite 934, New York , 10004

Quick Link

  • Why SMR
  • Research Methodology
  • Media Coverage
  • Join Our Team
  • Press Release
  • Blog

Customer Support

  • FAQs
  • Contact
  • Terms of Use
  • Privacy Policy
  • Disclaimer Policy
  • Return Policy
Copyright © 2022 Strategic Market Research All rights reserved.